These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

157 related items for PubMed ID: 16182838

  • 1. Improved liver function and decreased hepatitis C viral load after tacrolimus was replaced by cyclosporine.
    Lorho R, Turlin B, de Lajarte-Thirouard AS, Camus C, Lakehal M, Compagnon P, Meunier B, Boudjema K, Messner M.
    Transplant Proc; 2005; 37(6):2871-2. PubMed ID: 16182838
    [Abstract] [Full Text] [Related]

  • 2. Hepatitis C virus viral load after conversion from tacrolimus to cyclosporine in liver transplant patients: a pilot study.
    Guitard J, Sandres-Sauné K, Kamar N, Ribes D, Faguer S, Esposito L, Lavit M, Muscari F, Péron JM, Lavayssière L, Durand D, Rostaing L.
    Transplant Proc; 2007 Oct; 39(8):2603-5. PubMed ID: 17954189
    [Abstract] [Full Text] [Related]

  • 3. Hepatitis C virus recurrence after liver transplantation: influence of immunosuppressive regimens on viral load and liver histology.
    Oton E, Barcena R, Castillo M, Barreales M, Blesa C, Moreno-Planas JM, Barrios C, Garrido A, Cuervas V.
    Transplant Proc; 2006 Oct; 38(8):2499-501. PubMed ID: 17097980
    [Abstract] [Full Text] [Related]

  • 4. Impact of tacrolimus versus cyclosporine in hepatitis C virus-infected liver transplant recipients on recurrent hepatitis: a prospective, randomized trial.
    Martin P, Busuttil RW, Goldstein RM, Crippin JS, Klintmalm GB, Fitzsimmons WE, Uleman C.
    Liver Transpl; 2004 Oct; 10(10):1258-62. PubMed ID: 15376310
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Canadian national retrospective chart review comparing the long term effect of cyclosporine vs. tacrolimus on clinical outcomes in patients with post-liver transplantation hepatitis C virus infection.
    Yoshida EM, Lilly LB, Marotta PJ, Mason AL, Bilodeau M, Vaillancourt M.
    Ann Hepatol; 2013 Oct; 12(2):282-93. PubMed ID: 23396740
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Scarce influence of corticosteroid boluses on long-term viral load and liver histology in transplanted patients with recurrent hepatitis C.
    Barcena R, Oton E, Barreales M, Castillo M, Blesa C.
    Transplant Proc; 2006 Oct; 38(8):2502-4. PubMed ID: 17097981
    [Abstract] [Full Text] [Related]

  • 11. Conversion from tacrolimus to cyclosporine microemulsion therapy in liver transplant recipients.
    Ogino S, Hashikura Y, Katsuyama Y, Ikegami T, Nakazawa Y, Urata K, Terada M, Miyagawa S, Kawasaki S.
    Transplant Proc; 2004 Mar; 36(2 Suppl):299S-301S. PubMed ID: 15041357
    [Abstract] [Full Text] [Related]

  • 12. Long-term outcomes in liver transplant patients with hepatic C infection receiving tacrolimus or cyclosporine.
    Villamil F, Levy G, Grazi GL, Mies S, Samuel D, Sanjuan F, Rossi M, Lake J, Munn S, Mühlbacher F, Leonardi L, Cillo U.
    Transplant Proc; 2006 Nov; 38(9):2964-7. PubMed ID: 17112875
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Microemulsion cyclosporine with C2 monitoring and tacrolimus in liver transplantation with or without hepatitis C virus infection.
    Jain A.
    Liver Transpl; 2006 Oct; 12(10):1452-4. PubMed ID: 17004248
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Cyclosporine versus tacrolimus in patients with HCV infection after liver transplantation: effects on virus replication and recurrent hepatitis.
    Hilgard P, Kahraman A, Lehmann N, Seltmann C, Beckebaum S, Ross RS, Baba HA, Malago M, Broelsch CE, Gerken G.
    World J Gastroenterol; 2006 Feb 07; 12(5):697-702. PubMed ID: 16521181
    [Abstract] [Full Text] [Related]

  • 18. A retrospective study of conversion from tacrolimus-based to sirolimus-based immunosuppression in orthotopic liver transplant recipients.
    Yu S, He X, Yang L, Ma Y, Zhu X, Ju W, Huang J.
    Exp Clin Transplant; 2008 Jun 07; 6(2):113-7. PubMed ID: 18816237
    [Abstract] [Full Text] [Related]

  • 19. Amantadine monotherapy is ineffective in the treatment of hepatitis C virus recurrence in the post-liver transplantation setting.
    Muzi F, Orlando G, Ielpo B, Anselmo A, Sabato Ceraldi S, de Liguori Carino N, Manzia T, D'Andria D, Tariciotti L, Angelico M, Tisone G.
    Transplant Proc; 2005 May 07; 37(4):1705-7. PubMed ID: 15919438
    [Abstract] [Full Text] [Related]

  • 20. Cardiac function after orthotopic liver transplantation and the effects of immunosuppression: a prospective randomized trial comparing cyclosporin (Neoral) and tacrolimus.
    Therapondos G, Flapan AD, Dollinger MM, Garden OJ, Plevris JN, Hayes PC.
    Liver Transpl; 2002 Aug 07; 8(8):690-700. PubMed ID: 12149762
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.